Source: Myeloma – Hematology Advisor
Iberdomide plus dexamethasone demonstrated “meaningful” clinical activity in relapsed/refractory multiple myeloma, according to researchers.
Read More
by | Oct 27, 2022 | Myeloma News | 0 comments
Source: Myeloma – Hematology Advisor
Iberdomide plus dexamethasone demonstrated “meaningful” clinical activity in relapsed/refractory multiple myeloma, according to researchers.
Read More